InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: efood125 post# 80720

Saturday, 02/10/2018 8:42:22 AM

Saturday, February 10, 2018 8:42:22 AM

Post# of 144815
imo, the negative diabetes news/update was part of the reason for the sell off after the last CC. At best, the news was disappointing leaving investor sentiment doubtful (or uncertain in the meantime) for the Melligen cells and/or the alternative cells in use - as was the lack of cannabinoid progress.

The latest news however, referring to the PC therapy, has shed light on its continued progress. Its boosted renewed confidence in the therapy and boosted the sp back upward to its current level. But because the news didn't mention any positive updates on diabetes or cannabinoids, the uncertainty of their progress remains factored into the current sp (imo).

With that said, imo, without any foreseen catastrophes, the only news that would bring the sp back down at this point is negative PC news, which btw is now certainly limited (PC news).

So, for me, my expectation creates a narrower Stop Loss margin in my view. With great confidence I have raised my Stop Loss. :) :) :)


Go PharmaCyte!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News